Galena Biopharma Inc. (NASDAQ:GALE) had its target price decreased by stock analysts at S&P Equity Research from $0.61 to $0.50 in a research note issued on Friday. S&P Equity Research’s price target would indicate a potential downside of 19.03% from the stock’s previous close.http://www.webbreakingnews.com/2016/07/05/galena-biopharma-inc-gale-pt-lowered-to-0-50/